Cyclin B3 is a dominant fast-acting cyclin that drives rapid early embryonic mitoses
Journal of Cell Biology · 2024
DOI: 10.1083/jcb.202308034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Pablo Lara-Gonzalez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Caenorhabditis elegans Proteins, Cyclin B1, Embryo, Nonmammalian. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Ludwig Institute for Cancer Research, ODCDC CDC HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Mitosis in early embryos often proceeds at a rapid pace, but how this pace is achieved is not understood. Here, we show that cyclin B3 is the dominant driver of rapid embryonic mitoses in the C. elegans embryo. Cyclins B1 and B2 support slow mitosis (NEBD to anaphase ∼600 s), but the presence of cyclin B3 dominantly drives the approximately threefold faster mitosis observed in wildtype. Multiple mitotic events are slowed down in cyclin B1 and B2–driven mitosis, and cyclin B3–associated Cdk1 H1 kinase activity is ∼25-fold more active than cyclin B1–associated Cdk1. Addition of cyclin B1 to fast cyclin B3–only mitosis introduces an ∼60-s delay between completion of chromosome alignment and anaphase onset; this delay, which is important for segregation fidelity, is dependent on inhibitory phosphorylation of the anaphase activator Cdc20. Thus, cyclin B3 dominance, coupled to a cyclin B1–dependent delay that acts via Cdc20 phosphorylation, sets the rapid pace and ensures mitotic fidelity in the early C. elegans embryo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.
- Ludwig Institute for Cancer Research , La Jolla, CA, USA.
- Department of Cell and Developmental Biology, University of California, San Diego, San Diego, CA, USA.
- Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, CA, USA.
ORCID-Profile: Pablo Lara-Gonzalez, Smriti Variyar, Shabnam Moghareh, Anh Cao Ngoc Nguyen, Amrutha Kizhedathu, Jacqueline Budrewicz, Aleesa Schlientz, Neha Varshney, Andrew Bellaart, Karen Oegema, Lee Bardwell, Arshad Desai
Förderung
- Ludwig Institute for Cancer Research
- ODCDC CDC HHS
- NIGMS NIH HHS
- NIH HHS
- NIH Office of Research Infrastructure Programs
- National Institutes of Health
Zitieren
APA
Lara-Gonzalez, P., Variyar, S., Moghareh, S., Nguyen, A. C. N., Kizhedathu, A., Budrewicz, J., Schlientz, A., Varshney, N., Bellaart, A., Oegema, K., Bardwell, L., & Desai, A. (2024). Cyclin B3 is a dominant fast-acting cyclin that drives rapid early embryonic mitoses. Journal of Cell Biology. https://doi.org/10.1083/jcb.202308034
Vancouver
Lara-Gonzalez P, Variyar S, Moghareh S, Nguyen ACN, Kizhedathu A, Budrewicz J, et al. Cyclin B3 is a dominant fast-acting cyclin that drives rapid early embryonic mitoses. Journal of Cell Biology. 2024. doi:10.1083/jcb.202308034
BibTeX
@article{LaraGonzalez2024,
author = {Lara-Gonzalez, Pablo and Variyar, Smriti and Moghareh, Shabnam and Nguyen, Anh Cao Ngoc and Kizhedathu, Amrutha and Budrewicz, Jacqueline and Schlientz, Aleesa and Varshney, Neha and Bellaart, Andrew and Oegema, Karen and Bardwell, Lee and Desai, Arshad},
title = {Cyclin B3 is a dominant fast-acting cyclin that drives rapid early embryonic mitoses},
journal = {Journal of Cell Biology},
year = {2024},
doi = {10.1083/jcb.202308034}
}
EUVIMED